Michael John Tomsicek, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 14,800 shares at $91.39 ($1.4M) on 2020-09-01, disclosed to the SEC on 2020-09-03.
Open-market sale of $1.4M CRSP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.39 | 2,800 | $256K | 18.7% |
| 2 | $92.23 | 6,400 | $590K | 43.1% |
| 3 | $93.18 | 2,800 | $261K | 19.1% |
| 4 | $93.18 | 2,800 | $261K | 19.1% |
| Total | $92.43 avg | 14,800 | $1.4M | 100% |
| Filing → |
| CRSP | SELL | 2020-08-05 | $1.5M | — | Filing → |
| CBST | SELL | 2014-08-18 | $26K | — | Filing → |
| CBST | SELL | 2014-05-14 | $34K | — | Filing → |